Cargando…
MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
Chemotherapy resistance frequently drives tumour progression. However, the underlying molecular mechanisms are poorly characterized. In this study, we explored miR-137's role in the chemosensitivity of lung cancer. We found that the expression level of miR-137 is down-regulated in the human lun...
Autores principales: | Shen, Hua, Wang, Lin, Ge, Xin, Jiang, Cheng-Fei, Shi, Zhu-Mei, Li, Dong-Mei, Liu, Wei-Tao, Yu, Xiaobo, Shu, Yong-Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991488/ https://www.ncbi.nlm.nih.gov/pubmed/26989074 http://dx.doi.org/10.18632/oncotarget.8011 |
Ejemplares similares
-
MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1
por: Wang, Lin, et al.
Publicado: (2015) -
MicroRNA-34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
por: Yanokura, Megumi, et al.
Publicado: (2020) -
MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2
por: Liu, Mei, et al.
Publicado: (2019) -
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015) -
The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells
por: Jin, Yanshan, et al.
Publicado: (2023)